To understand the rules regarding the handling of CBD at EU level To standardize, the ECJ has now stipulated that the EU member states may not prohibit the marketing of CBD products that have been produced in another EU country in compliance with the law. Above all, this regulation is intended to prevent different production processes and the use of different plant components in another country from leading to a general ban in one's own country (see case C-663/18, BS and CA).

The origin of the new and current case law in France. Here traders had problems with the law because they had sold Czech liquids with CBD for their e-cigarettes. They appealed and the case eventually went to the European Court of Justice.

Now he has spoken a word of power and the judgment should point the way for all traders of CBD products. Because in its remarks, the ECJ clearly states that CBD (unlike THC) "apparently has no psychotropic effects or harmful effects" on the body. Conversely, CBD is neither a drug nor an anesthetic. It must therefore no longer fall under the strict regulations of the Narcotics Act. And as always, when there is a new judgment from the European Court of Justice, it also calls into question previous national judgments, especially since this judgment clearly states how the EU member states should deal with each other. On the contrary: From now on, CBD should be allowed to be traded as food. The entire process of manufacturing and selling CBD products is therefore subject to the case law and legal situation of food.

Another consequence of the ruling of the European Court of Justice is the handling of intra-European trade. Up to now, the applicable laws in the importing country have applied here. Not anymore. Instead, the ECJ generally stipulated that CBD was no longer an addictive substance and that it had to be freely tradable.